Ensol Biosciences (XKRX:140610) Days Sales Outstanding : 92.86 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Ensol Biosciences Days Sales Outstanding?

Ensol Biosciences's average Accounts Receivable for the six months ended in Dec. 2023 was ₩44.9 Mil. Ensol Biosciences's Revenue for the six months ended in Dec. 2023 was ₩176.5 Mil. Hence, Ensol Biosciences's Days Sales Outstanding for the six months ended in Dec. 2023 was 46.43.

The historical rank and industry rank for Ensol Biosciences's Days Sales Outstanding or its related term are showing as below:

XKRX:140610' s Days Sales Outstanding Range Over the Past 10 Years
Min: 8.73 Med: 30.12 Max: 104.46
Current: 92.86

During the past 10 years, Ensol Biosciences's highest Days Sales Outstanding was 104.46. The lowest was 8.73. And the median was 30.12.

XKRX:140610's Days Sales Outstanding is ranked worse than
63.34% of 881 companies
in the Biotechnology industry
Industry Median: 72.67 vs XKRX:140610: 92.86

Ensol Biosciences's Days Sales Outstanding increased from Dec. 2021 (14.70) to Dec. 2023 (92.86).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Ensol Biosciences Days Sales Outstanding Historical Data

The historical data trend for Ensol Biosciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ensol Biosciences Days Sales Outstanding Chart

Ensol Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

9.46

8.73

14.70

13.69

92.86

Ensol Biosciences Semi-Annual Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial					9.46	8.73	14.70	13.69	92.86

Competitive Comparison of Ensol Biosciences's Days Sales Outstanding

For the Biotechnology subindustry, Ensol Biosciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ensol Biosciences's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ensol Biosciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ensol Biosciences's Days Sales Outstanding falls into.

Ensol Biosciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ensol Biosciences's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (32.23	+	57.602)	/	2 )	/	176.545	*	365
=	44.916					/	176.545	*	365
=	92.86

Ensol Biosciences's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (32.23	+	57.602)	/	2 )	/	176.545	*	365 / 2
=	44.916					/	176.545	*	365 / 2
=	46.43

Ensol Biosciences (XKRX:140610) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Ensol Biosciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ensol Biosciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Ensol Biosciences (XKRX:140610) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ensol Biosciences Inc (XKRX:140610) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

51, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34036

Website

http://www.ensolbio.co.kr

Ensol Biosciences Inc is a Korean big data-driven biopharmaceutical company. The company is engaged in developing drugs for the diseases that have no therapeutic alternatives, such as a degenerative disc, osteoarthritis, cancer, Alzheimer's dementia, and type 1 diabetes. Its drugs portfolio includes Peniel 2000 Drug for Degenerative Disc Disease, Engedi 1000 Drug for Osteoarthritis, Charis 1000 Drug for Immuno-Oncology, Moriah 1000 Drug for Alzheimer's Disease, Shiloah 1000 Drug for Type I Diabetes, and EAD100 Drug for Animal Osteoarthritis.

Ensol Biosciences (XKRX:140610) Headlines

No Headlines